Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915
Eli Lilly and Co Analyst Ratings
Argus Adjusts Price Target on Eli Lilly to $840 From $770
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Raises Price Target to $885
Eli Lilly and Co Analyst Ratings
Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating
Eli Lilly and Co Analyst Ratings
Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Goldman Sachs Maintains Neutral on Eli Lilly and Co, Raises Price Target to $723
Eli Lilly and Co Analyst Ratings
No Data